You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
BMY 14802 hydrochloride
Discontinued ProductBMY 14802 hydrochloride (Cat. No. 1440) has been withdrawn from sale for commercial reasons.
Biological Activity for BMY 14802 hydrochloride
BMY 14802 hydrochloride is a potent sigma receptor antagonist (IC50 = 112 nM) with modest to weak affinity for 5-HT1A and α1 receptors. Antipsychotic following oral administration and acts via indirect modulation of central dopaminergic systems.
Sold with the permission of Bristol-Myers Squibb Company
Technical Data for BMY 14802 hydrochloride
|Storage||Desiccate at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Product Datasheets for BMY 14802 hydrochloride
References for BMY 14802 hydrochloride
References are publications that support the biological activity of the product.
Taylor et al (1993) A role for sigma binding in the antipsychotic profile of BMY 14802? NIDA Res.Monogr. 133 125 PMID: 8232511
Yevich et al (1992) Synthesis and biological characterization of α-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents. J.Med.Chem. 35 4516 PMID: 1361578
Zhang et al (1993) Further characterization of the effects of BMY 14802 on DA neuronal activity. Synapse 15 276 PMID: 7908761
View Related Products by Product Action
Keywords: BMY 14802 hydrochloride, BMY 14802 hydrochloride supplier, σ, sigma, antagonists, Antipsychotic, agent, General, Receptors, BMY14802, Sigma-Related, 1440, Tocris Bioscience
2 Citations for BMY 14802 hydrochloride
Citations are publications that use Tocris products. Selected citations for BMY 14802 hydrochloride include:
Paquette et al (2008) σ ligands, but not N-MthD.-aspartate antagonists, reduce levodopa-induced dyskinesias. Reprod Biol Endocrinol 19 111 PMID: 18281903
Bhide et al (2013) The effects of BMY-14802 against L-DOPA- and DA agonist-induced dyskinesia in the hemiparkinsonian rat. Psychopharmacology (Berl) 227 533 PMID: 23389756
Reviews for BMY 14802 hydrochloride
There are currently no reviews for this product. Be the first to review BMY 14802 hydrochloride and earn rewards!
Have you used BMY 14802 hydrochloride?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image